| Title |
Author |
Type |
Date |
Words |
| Short Communication - BMP4 and Rosiglitazone Improves Adipogenesis of Bovine Fetal Muscle Derived Progenitor Cells. |
Yahui Wang, Ling Ren, Yishen Xing, Xin Hu, Qian Li, Lingyang Xu, Junya Li and Lupei Zhang |
|
Feb 24, 2021 |
2659 |
| [alpha]-Glucosidase Inhibitor Can Effectively Inhibit the Risk of Tuberculosis in Patients with Diabetes: A Nested Case-Control Study. |
Lin, Kai-Huang; Luo, Ci-Wen; Chen, Shih-Pin; Tu, Dom-Gene; Lin, Ming-Shian; Kuan, Yu-Hsiang |
Report |
Jun 30, 2020 |
8849 |
| PPAR[gamma] and Its Agonists in Chronic Kidney Disease. |
Ma, Yuhua; Shi, Manman; Wang, Yuxin; Liu, Jian |
|
Mar 31, 2020 |
8157 |
| Transdifferentiation of bovine epithelial cells towards adipocytes in the presence of myoepithelium. |
Sugathan, Subi; Lee, Sung-Jin; Shiwani, Supriya; Singh, Naresh Kumar |
|
Feb 1, 2020 |
5847 |
| Altered Expression of Long Noncoding and Messenger RNAs in Diabetic Nephropathy following Treatment with Rosiglitazone. |
Zhang, Liwen; Zhou, Ying; Zhou, Fangfang; Yu, Xialian; Liu, Jian; Liu, Yunzi; Zhu, Yufei; Wang, Weim |
|
Jan 1, 2020 |
8020 |
| Rosiglitazone Suppresses Calcium Oxalate Crystal Binding and Oxalate-Induced Oxidative Stress in Renal Epithelial Cells by Promoting PPAR-[gamma] Activation and Subsequent Regulation of TGF-[beta]1 and HGF Expression. |
Liu, Ya-Dong; Yu, Shi-Liang; Wang, Rui; Liu, Jian-Nan; Jin, Yin-Shan; Li, Yi-Fu; An, Rui-Hua |
|
Nov 30, 2019 |
7702 |
| DPP4 Inhibitors Do Not Up Risk of Inflammatory Bowel Disease; Findings based on comparison to sulfonylureas, thiazolidinediones. |
|
|
Sep 27, 2019 |
259 |
| Peroxisome Proliferator-Activated Receptor-[gamma] Antagonizes LOX-1-Mediated Endothelial Injury by Transcriptional Activation of miR-590-5p. |
Xu, Lei; Zhao, Gang; Zhu, Hong; Wang, Shijun; Sun, Aijun; Zou, Yunzeng; Ge, Junbo |
|
Jul 31, 2019 |
5219 |
| Expression of Concern on "The Novel Oral Drug Subetta Exerts an Antidiabetic Effect in the Diabetic Goto-Kakizaki Rat: Comparison with Rosiglitazone". |
|
|
Jul 31, 2019 |
1396 |
| Rosiglitazone Improves Glucocorticoid Resistance in a Sudden Sensorineural Hearing Loss by Promoting MAP Kinase Phosphatase-1 Expression. |
Xia, Liang; Liu, Jingjing; Sun, Yuanyuan; Shi, Haibo; Yang, Guang; Feng, Yanmei; Yin, Shankai |
|
May 31, 2019 |
5372 |
| Synthesis and Aldose Reductase Inhibitory Effect of Some New Hydrazinecarbothioamides and 4-Thiazolidinones Bearing an Imidazo[2,1-b] Thiazole Moiety/Imidazo[2,1-b]Tiyazol Cekirdegi Tasiyan Bazi Yeni Hidrazinkarbotiyoamitler ve 4-Tiyazolidinonlarin Sentezi ve Aldoz Reduktaz Inhibitor Etkileri. |
Guzeldemirci, Nuray Ulusoy; Cimok, Selin; Das-Evcimen, Net; Sarikaya, Mutlu |
Report |
Mar 1, 2019 |
7052 |
| THE EFFECT OF TROGLITAZONE ON C- REACTIVE PROTEIN IN INDIVIDUALS WITH PREDIABETES: DATA FROM THE DIABETES PREVENTION PROGRAM. |
Mokthar, Khalid; Hamadain, Elgenaid |
Report |
Apr 1, 2018 |
7865 |
| Differential characterization of myogenic satellite cells with linolenic and retinoic acid in the presence of thiazolidinediones from prepubertal Korean black goats. |
Subi, S.; Lee, S.J.; Shiwani, S.; Singh, N.K. |
Report |
Mar 1, 2018 |
6493 |
| Antidiabetic Activity of Picris japonica Thunb Aqueous Extract in Diabetic KK-[A.sup.y] Mice. |
Jia, Yanmei; Chen, Lirong |
|
Jan 1, 2018 |
3335 |
| Expression of GPR43 in Brown Adipogenesis Is Enhanced by Rosiglitazone and Controlled by PPAR[gamma]/RXR Heterodimerization. |
Hu, Jiamiao; Zhou, Arong; Cheung, Peter C.K.; Zheng, Baodong; Zeng, Shaoxiao; Lin, Shaoling |
|
Jan 1, 2018 |
4326 |
| Combined Rosiglitazone and Forskolin Have Neuroprotective Effects in SD Rats after Spinal Cord Injury. |
Meng, Qing-qi; Lei, Wei; Chen, Hao; Feng, Zhen-cheng; Hu, Li-qiong; Zhang, Xing-liang; Li, Siming |
|
Jan 1, 2018 |
7281 |
| Treatment with Lobeglitazone Attenuates Hepatic Steatosis in Diet-Induced Obese Mice. |
Choung, Sorim; Joung, Kyong Hye; You, Bo Ram; Park, Sang Ki; Kim, Hyun Jin; Ku, Bon Jeong |
|
Jan 1, 2018 |
4713 |
| Rosiglitazone Elicits an Adiponectin-Mediated Insulin-Sensitizing Action at the Adipose Tissue-Liver Axis in Otsuka Long-Evans Tokushima Fatty Rats. |
Li, Jia; Xue, Yao-Ming; Zhu, Bo; Pan, Yong-Hua; Zhang, Yan; Wang, Chunxia; Li, Yuhao |
|
Jan 1, 2018 |
6008 |
| Synthesis, Crystal Structure and Biological Evaluation of 5-Arylidine derivatives of 3-Phenyl-2-(phenylimino)thiazolidin-4-one. |
Haroon, Muhammad; Akhtar, Tashfeen; Tahir, Muhammad Nawaz; Ali, Imran; Hameed, Shahid |
Report |
Aug 31, 2017 |
3302 |
| Rosiglitazone Role in the Expression of KLF6 Caco-2 Colon Cancer Cells/Rol de Rosiglitazona en la Expresion de KLF6 en Celulas Caco-2 de Cancer de Colon. |
Rojas, Victor; Laime, Delia |
|
Mar 1, 2017 |
3355 |
| Targeting Peroxisome Proliferator-Activated Receptors Using Thiazolidinediones: Strategy for Design of Novel Antidiabetic Drugs. |
Thangavel, Neelaveni; Bratty, Mohammed Al; Javed, Sadique Akhtar; Ahsan, Waquar; Alhazmi, Hassan A. |
Report |
Jan 1, 2017 |
12237 |
| Neuroprotective Effect and Mechanism of Thiazolidinedione on Dopaminergic Neurons In Vivo and In Vitro in Parkinson's Disease. |
Wang, Yanqin; Zhao, Weilin; Li, Ge; Chen, Jinhu; Guan, Xin; Chen, Xi; Guan, Zhenlong |
Report |
Jan 1, 2017 |
6193 |
| Deciphering the Roles of Thiazolidinediones and PPAR[gamma] in Bladder Cancer. |
Chiu, Melody; McBeth, Lucien; Sindhwani, Puneet; Hinds, Terry D. |
Report |
Jan 1, 2017 |
7920 |
| 2,4-Thiazolidinedione Treatment Improves the Innate Immune Response in Dairy Goats with Induced Subclinical Mastitis. |
Rosa, Fernanda; Osorio, Johan S.; Trevisi, Erminio; Yanqui-Rivera, Francisco; Estill, Charles T.; Bi |
Report |
Jan 1, 2017 |
14427 |
| Fluid Retention Caused by Rosiglitazone Is Related to Increases in AQP2 and [alpha]ENaC Membrane Expression. |
Xu, Jinghua; Pan, Mingyue; Wang, Xiaoli; Xu, Lishi; Li, Lanfang; Xu, Cheng |
Report |
Jan 1, 2017 |
4459 |
| Discovery of Novel Insulin Sensitizers: Promising Approaches and Targets. |
Chen, Yadan; Ma, Haiming; Zhu, Dasheng; Zhao, Guowei; Wang, Lili; Fu, Xiujuan; Chen, Wei |
Report |
Jan 1, 2017 |
10179 |
| A Sustained-Release Membrane of Thiazolidinedione-8: Effect on Formation of a Candida/Bacteria Mixed Biofilm on Hydroxyapatite in a Continuous Flow Model. |
Feldman, Mark; Shenderovich, Julia; Lavy, Eran; Friedman, Michael; Steinberg, Doron |
Report |
Jan 1, 2017 |
6107 |
| Electroacupuncture Reduces Weight Gain Induced by Rosiglitazone through PPAR[gamma] and Leptin Receptor in CNS. |
Jing, Xinyue; Ou, Chen; Chen, Hui; Wang, Tianlin; BinXu; Lu, Shengfeng; Zhu, Bing- Mei |
|
Jan 1, 2016 |
6797 |
| IADC amicus brief program. |
Owen, Robert D. |
|
Oct 1, 2015 |
5655 |
| Bisphosphonates for bone--and advice on ARVs, calcium, vitamin D, glitazones. |
Mascolini, Mark |
Report |
Sep 22, 2015 |
2821 |
| Prescribing pattern of antidiabetic drugs in urban population of hyderabad. |
Rani, Jamuna; Reddy, Sambasiva |
|
Jan 1, 2015 |
2541 |
| The effect of Tianmai Xiaoke Pian on insulin resistance through PI3-K/AKT signal pathway. |
Wang, Nana; Li, Tiegang; Han, Ping |
|
Jan 1, 2015 |
3635 |
| U.S. jury orders Takeda Pharmaceutical company to pay $6 bln over Actos claims. |
|
|
Apr 8, 2014 |
152 |
| Restrictions pulled on GSK's Avandia. |
|
|
Dec 16, 2013 |
546 |
| Rosiglitazone may not up heart risk in CAD patients. |
Mechcatie, Elizabeth |
|
Aug 1, 2013 |
1060 |
| GSK to Pay $229m to Settle Eight US States Lawsuits over Avandia. |
|
|
Jul 25, 2013 |
414 |
| Effects of dietary thiazolidinedione supplementation on growth performance, intramuscular fat and related genes mRNA abundance in the longissimus dorsi muscle of finishing pigs. |
Chen, X.; Feng, Y.; Yang, W.J.; Shu, G.; Jiang, Q.Y.; Wang, X.Q. |
Report |
Jul 1, 2013 |
6896 |
| Catalyst-free synthesis of highly biologically active 5-arylidene rhodanine and 2,4-thiazolidinedione derivatives using aldonitrones in polyethylene glycol. |
Kumar, Dhruva; Narwal, Suresh; Sandhu, Jagir S. |
Report |
Jan 1, 2013 |
2543 |
| Wright & McGurk Announces New Campaign to Help Actos[R] Patients Diagnosed with Bladder Cancer. |
|
|
Dec 6, 2012 |
463 |
| Watson Pharmaceuticals Inc unveils FDA approved generic Actos. |
|
|
Oct 29, 2012 |
107 |
| Watson Pharmaceuticals Inc unveils FDA approved generic Actos. |
|
|
Oct 29, 2012 |
103 |
| Mylan is first to market with a version of Actos. |
|
|
Sep 24, 2012 |
187 |
| Teva Pharmaceutical Industries Ltd introduces generic Actos to improve blood sugar control in adults with type 2 diabetes in the US. |
|
|
Aug 20, 2012 |
127 |
| Teva Pharmaceutical Industries Ltd introduces generic Actos to improve blood sugar control in adults with type 2 diabetes in the US. |
|
|
Aug 20, 2012 |
123 |
| Glaxo agrees to pay $956.8 million criminal fine. |
|
|
Jul 2, 2012 |
310 |
| Hypoglycemics for the treatment of type 2 diabetes in patients with chronic kidney disease: a focus on new agents. |
Lori D., Victor Fang; PharmD, Wazny; Raymond, Colette B. |
|
Jan 1, 2012 |
6052 |
| New Actos Bladder Cancer Resource Center Offers Answers to Concerned Patients. |
|
|
Dec 8, 2011 |
444 |
| The relation of changes in prescribing patterns of anti-diabetic drugs and [HbA.sub.1c] levels among patients with type 2 diabetes mellitus: systematic analysis of studies from the the past 20 years in turkey/Antidiyabetik ilac kullanim paternlerindeki degisim ile tip 2 diabetes mellituslu hastalarda [HbA.sub.1c] duzeyi arasindaki iliski: turkiye'de son 20 yilda yapilan calismalarin sistematik analizi. |
Ilkova, Hasan; Damci, Taner; Siva, Zeynep Osar; Ozyazar, Mucahit; Yumuk, Volkan; Gorpe, Esat Ugur; H |
|
Dec 1, 2011 |
21834 |
| SideEffectActos.com: New Website Offers Help to Actos Bladder Cancer Patients. |
|
Website overview |
Nov 28, 2011 |
410 |
| Actos-Bladder Cancer Cases Are Becoming Prevalent, New York Attorney Reports. |
|
|
Sep 7, 2011 |
400 |
| Avoid TZDs to preserve bone density in diabetes patients. |
Boschert, Sherry |
|
Sep 1, 2011 |
532 |
| Avoid thiazolidinediones to preserve bone. |
Boschert, Sherry |
Report |
Sep 1, 2011 |
650 |
| 12 Takeda Pharmaceutical Co. |
|
|
Jul 1, 2011 |
1446 |
| Pioglitazone limits progression to type 2 diabetes. |
Moon, Mary Ann |
|
Apr 1, 2011 |
716 |
| Pioglitazone slowed progression to diabetes. |
Moon, Mary Ann |
|
Apr 1, 2011 |
658 |
| Minimizing litigation pain: in the wake of the reports of the negative effects of the Avandia litigation on GSK's profits, now is a good time to reflect on the role of lawyers and litigation. |
Brozolo, Luca G. Radicati di |
|
Mar 1, 2011 |
1050 |
| Avandia: explore alternatives: in light of regulatory action, talk to your doctor about other drugs to control your blood sugar and manage your diabetes. |
|
|
Jan 1, 2011 |
961 |
| Diabetes oral medications: an overview of side effects and safety concerns: the use of rosiglitazone (Avandia) has been restricted, but many other drug options are available. |
|
|
Nov 1, 2010 |
815 |
| Pioglitazone studied as Alzheimer's treatment. |
Mechcatie, Elizabeth |
|
Oct 15, 2010 |
582 |
| Thiazolidinediones linked to increased fracture risk. |
Finn, Robert |
|
Oct 1, 2010 |
337 |
| Actos's safety under review. |
|
|
Oct 1, 2010 |
207 |
| Safety of Actos under review. |
|
|
Oct 1, 2010 |
210 |
| Alternative medications exist for controversial diabetes drug: patients concerned about rosiglitazone (Avandia) should talk with their doctors about other options. |
|
|
Oct 1, 2010 |
705 |
| Avandia to stay on market with restrictions. |
|
Brief article |
Oct 1, 2010 |
145 |
| Diabetics warned about Avandia. |
|
|
Sep 28, 2010 |
231 |
| Diabetes drug to be withdrawn. |
|
|
Sep 27, 2010 |
469 |
| New Avandia[R] Restrictions in the US / Peterson & Assoc., P.C. is Committed to Inform Patients at New Website. |
|
Website overview |
Sep 27, 2010 |
416 |
| Health Ministry revokes, withdraws Avandia drug dispensed for diabetic patients. |
|
|
Sep 25, 2010 |
282 |
| DIABETES PILL IS 'TOO RISKY' FOR PATIENTS; Heart attack fears over Avandia. |
|
|
Sep 24, 2010 |
167 |
| GlaxoSmithKline says EMA suspends, FDA restricts use of Avandia. |
|
|
Sep 24, 2010 |
466 |
| EU told to ban three diabetes drugs. |
|
|
Sep 23, 2010 |
416 |
| FDA to review safety information on Takeda's Actos. |
|
|
Sep 21, 2010 |
180 |
| Diabetes drug comes under scrutiny. |
|
|
Sep 8, 2010 |
390 |
| UK watchdog to withdraw GSK diabetes drug Avandia. |
|
|
Sep 6, 2010 |
181 |
| Avandia alert. |
Etingin, Orli R. |
Clinical report |
Sep 1, 2010 |
256 |
| Friends don't let friends take Avandia. |
Massion, Charlea T.; Fugh-Berman, Adriane |
|
Sep 1, 2010 |
1087 |
| TZD may boost fracture risk for men, women. |
Tucker, Miriam E. |
Report |
Sep 1, 2010 |
606 |
| TZDs tied to fracture risk in postmenopausal women. |
Finn, Robert |
|
Sep 1, 2010 |
470 |
| FDA panels: Avandia stay--with safety scrutiny. |
Ault, Alicia |
|
Aug 1, 2010 |
1140 |
| Thiazolidinediones tied to increased risk of fracture. |
Finn, Robert |
|
Aug 1, 2010 |
466 |
| Study raises hope for safer diabetes drugs. |
|
|
Jul 21, 2010 |
453 |
| Glaxo plans huge liability charge on Avandia, Paxil. GlaxoSmithKline Plc. |
|
|
Jul 19, 2010 |
424 |
| FDA disputes finding that Glaxo's Avandia is safe. |
|
Clinical report |
Jul 12, 2010 |
363 |
| A new study led by a federal drug safety expert ties the controversial diabetes drug Avandia to a higher risk of heart problems, strokes and deaths in older adults, and says it is more dangerous than a rival drug, Actos. |
|
|
Jul 5, 2010 |
393 |
| Avandia suspected in deaths. |
Anderson, Jane |
Brief article |
Jul 1, 2010 |
119 |
| Your diabetes meds may be doing more harm than good: if you're taking Avandia, you may want to talk to your doctor about its potential side effects and dangers. |
|
|
Jun 1, 2010 |
401 |
| Glaxo to pay $60 million in Avandia settlements. GlaxoSmithKline Plc. |
|
|
May 17, 2010 |
316 |
| Thiazolidinediones appear safe for diabetic eyes. |
Johnson, Kate |
Clinical report |
May 1, 2010 |
598 |
| Therapy of diabetes mellitus using experimental animal models. |
Min, T.S.; Park, S.H. |
Report |
May 1, 2010 |
6156 |
| Fracture tied to diabetes risk. |
|
Brief article |
Mar 15, 2010 |
140 |
| Senate committee, industry clash over Avandia. |
Frieden, Joyce |
|
Mar 15, 2010 |
789 |
| Disparity seen in decline of Glitazone use. |
Kuttler, Hillel |
|
Mar 1, 2010 |
478 |
| Diabetes drug 'ups heart disease, death risk'. |
|
|
Feb 22, 2010 |
322 |
| Takeda, Pfizer to co-promote Type 2 diabetes drug Actos in China. |
|
|
Dec 16, 2009 |
145 |
| The metabolic syndrome in diabetic Hispanic adults and the role of secondary actos treatment in insulin sensitivity based on gender. |
Goonatilake, Rohitha; Rosenow, Doris J.; Lara, Irma A.; Palacios, Horacio; Villarreal, Gustavo E. |
Clinical report |
Dec 1, 2009 |
5174 |
| Differential action of trans-10, cis-12 conjugated linoleic acid on adipocyte differentiation of ovine and 3T3-L1 preadipocytes. |
Iga, T.; Satoh, T.; Yamamoto, S.; Fukui, K.; Song, S.H.; Choi, K.C.; Roh, S.G.; Sasaki, S. |
Report |
Nov 1, 2009 |
4420 |
| Diabetes raises dementia risk, but drugs may lower it: diabetes can cause vascular dementia, but medications may help prevent this complication. |
|
|
May 1, 2009 |
618 |
| TZD use is linked to increased risk of bone fracture. |
Zoler, Mitchel L. |
Report |
Apr 1, 2009 |
596 |
| The effects of hydroxycinnamic acid derivatives on adiponectin secretion. |
Ohara, Kazuyuki; Uchida, Asako; Nagasaka, Reiko; Ushio, Hideki; Ohshima, Toshiaki |
Report |
Mar 1, 2009 |
4178 |
| Use of glitazone associated with diabetic macular edema. |
Lesney, Mark S. |
|
Mar 1, 2009 |
388 |
| Pioglitazone in prediabetes curbs disease progression. |
Boschert, Sherry |
Clinical report |
Jul 1, 2008 |
835 |
| Pioglitazone enhances niacin's effect in raising serum HDL. |
Zoler, Mitchel L. |
|
Jul 1, 2008 |
562 |
| Pioglitazone cuts risk of progression to diabetes. |
Boschert, Sherry |
Clinical report |
Jul 1, 2008 |
776 |
| Pioglitazone cuts risk of progression to diabetes. |
Boschert, Sherry |
Clinical report |
Jul 1, 2008 |
776 |
| Pioglitazone for prediabetes is found to reduce 3-year disease progression 81%. |
Boschert, Sherry |
Clinical report |
Jul 1, 2008 |
623 |
| Which diabetes drug is best for you? In light of heart-risk concerns associated with TZDs, talk with your doctor about other options. |
|
|
Jun 1, 2008 |
531 |
| Rosiglitazone patient guide addresses heart failure, other cardiac concerns. |
Mechcatie, Elizabeth |
|
May 1, 2008 |
201 |
| Subtle shift in guidelines for prediabetes. |
Boschert, Sherry |
|
Apr 15, 2008 |
428 |
| Pioglitazone may lower cardiovascular risk in CKD patients. |
Wachter, Kerri |
Clinical report |
Feb 1, 2008 |
931 |
| Updated guidelines allow cautious use of TZDs. |
Tucker, Miriam E. |
|
Jan 1, 2008 |
624 |
| Guidelines urge caution on thiazolidinediones. |
Tucker, Miriam E. |
|
Dec 15, 2007 |
629 |
| Pioglitazone may lower risk of MI, stroke. |
Moon, Mary Ann |
|
Oct 15, 2007 |
489 |
| Consider alternatives to controversial drug: if you're concerned about using rosiglitazone for your diabetes, a leading heart expert recommends talking to your doctor about other options to control your blood sugar. |
|
|
Oct 1, 2007 |
631 |
| Thiazolidinediones receive black box for heart failure: careful monitoring of patients advised. |
Mechcatie, Elizabeth |
|
Sep 1, 2007 |
568 |
| Rosiglitazone: failure of oversight or demons imagined? |
Susman, Jeff |
|
Sep 1, 2007 |
780 |
| TZDs given black box warning on heart failure. |
Mechcatie, Elizabeth |
|
Sep 1, 2007 |
637 |
| FDA panel favors keeping c on market. |
Ault, Alicia |
|
Aug 15, 2007 |
1261 |
| Analysis links thiazolidinediones to heart failure risk. |
Evans, Jeff |
|
Aug 15, 2007 |
419 |
| Exposure to diabetes drugs reduces risk of squamous cell carcinoma, study finds. |
Wachter, Kerri |
|
Jul 15, 2007 |
662 |
| Accusations abound during hearing on Avandia. |
Frieden, Joyce |
|
Jun 15, 2007 |
868 |
| Analysis ties rosiglitazone to increased MI risk. |
Evans, Jeff |
Report |
Jun 1, 2007 |
1037 |
| Metformin & glitazones: do they really help PCOS patients? While the use of metformin and thiazolidenediones in treating PCOS patients is fairly common, this review revealed little evidence-based support for the practice. |
Pillai, Anush S.; Bang, Heejung; Green, Charles |
Clinical report |
Jun 1, 2007 |
5715 |
| Thiazolidinediones may protect against Alzheimer's disease. |
Sullivan, Michelle G. |
|
Aug 15, 2006 |
504 |
| Diabetes drug class may lower risk of Alzheimer's. |
Sullivan, Michele G. |
|
Aug 15, 2006 |
527 |
| Type II diabetics. |
|
Brief article |
Feb 1, 2006 |
92 |
| Do TZDs increase the risk of heart failure for patients with diabetes? |
Baskin, Serena; Neher, John O.; Dodson, Sherry |
|
Aug 1, 2005 |
922 |
| Women's weight gain higher on thiazolidinedione. |
Tucker, Miriam E. |
Brief Article |
Jul 1, 2005 |
220 |
| Women often gain weight on thiazolidinediones. |
Tucker, Miriam E. |
Brief Article |
Jul 1, 2005 |
267 |
| TZD use in heart failure: not that bad after all? |
Wendling, Patrice |
|
May 15, 2005 |
482 |
| TZD use in heart failure: not that bad after all? |
Wendling, Patrice |
Brief Article |
Mar 1, 2005 |
308 |
| Do insulin-sensitizing drugs increase ovulation rates for women with PCOS? |
Andy, Camille; Flake, Donna |
|
Feb 1, 2005 |
1483 |
| Treating type 2 diabetes: targeting the causative factors. |
Sutherland, John E.; Hoehns, James D. |
|
May 1, 2004 |
7048 |
| Guideline targets edema, CHF risk in diabetes; thiazolidiendiones. |
Tucker, Miriam E. |
|
Feb 1, 2004 |
775 |
| Nonalcoholic fatty liver disease in type 2: diabetes: obese adolescents. |
Tucker, Miriam E. |
|
Feb 1, 2004 |
400 |
| Guidelines target edema risk, thiazolidinediones: concern about CHF in type 2 diabetes. |
Tucker, Miriam E. |
|
Jan 15, 2004 |
782 |
| Thiazolidinediones useful against diabetes after heart failure: don't be fazed by fluid retention. |
Kirn, Timothy F. |
|
Jan 1, 2004 |
442 |
| Diabetes drugs reduce symptoms. (Multiple Sclerosis). |
|
|
Feb 1, 2003 |
338 |
| How beneficial are thiazolidinediones for diabetes mellitus? (Clinical Inquiries). |
Culhane, Nicole S.; Graves, Rebecca |
Brief Article |
May 1, 2002 |
796 |
| Which oral antihyperglycemics are most efficacious in reducing hemoglobin [A.sub.1C] in diabetic patients? (Patient-Oriented Evidence that Matters). |
Abrahamson, Lara; Newton, Warren |
|
Apr 1, 2002 |
660 |
| UPDATE: Thiazolidinedione Group. |
|
Pamphlet |
May 24, 2000 |
463 |
| Glitazones Assessed as Antihypertensives Agents. |
ZOLER, MITCHEL L. |
|
Dec 1, 1999 |
302 |
